This message was sent to ##Email## January 24, 2019     Home  |   About   Subscribe  |   Archive  |   Advertise    ACS CANCER PROGRAMS UPDATES Experience Rosemont while attending the Cluster Programs ACS April 7–9 Don’t waste your evening in your hotel room while attending the Cluster Programs. There are endless amounts of activities to enjoy during your stay! The Crowne Plaza hotel is located in Rosemont, IL, and is full of nearby options for shopping and dining. With 75,000 visitors every day, this thriving suburb is known for its entertainment venues and business tourism. Be sure to check out Rosemont's many attractions, such as Donald E. Stephens Convention Center, Allstate Arena, Rosemont Theatre and the Fashion Outlets of Chicago, just a block away, and its numerous restaurants. Register now to take advantage of the early-bird registration fee. Seats are limited. Further information is available on the Cluster Programs website. If you have any questions or comments, please contact us at CancerProgramsEvents@facs.org.  READ MORE NCDB PUF application period opens Jan. 28 ACS The National Cancer Database (NCDB) is pleased to announce that the Participant User File (PUF) application will open on Jan. 28. The NCDB will accept applications for site-specific files, which will include cases diagnosed between 2004 and 2016. The application period will be open through March 1. Click here for more information. There are several changes to the variables in the 2016 PUF, which are described in the “Summary of 2016 PUF Data Changes” document found here.    SPONSORED CONTENT Promoted by CHAMPS Oncology CHAMPS Oncology Outlook features posts on the industry, careers and more: Developing Goals for CoC Compliance Cancer Registry Abstracting Tips for 2018+ My CHAMPS Oncology CTR Practicum Experience Workspace Tips for the Remote CTR   US cancer statistics data now available at the congressional district level CDC CDC’s Division of Cancer Prevention and Control is pleased to announce the addition of the new Congressional District module to the United States Cancer Statistics: Data Visualizations tool, a user-friendly product that allows cancer surveillance data to be directly and more easily accessible by the public. The new Congressional District module allows users to view estimated cancer incidence and mortality counts and rates by congressional district. Estimates are presented by cancer type, sex (both sexes, male and female) and race and ethnicity (all races, non-Hispanic white, black and Hispanic). Click here to access the tool. For questions, please contact us at uscsdata@cdc.gov . 2019 Program Activity Record (PAR) release ACS The updated 2019 PAR is now available to all accredited cancer programs not scheduled for survey in 2019 through CoC Datalinks. All previous PARs are now closed and cannot be re-opened. All cancer programs should only be entering activity in the 2019 version of the SAR or PAR. The PAR will allow you to add, delete or edit any information or uploaded documentation for 2016, 2017, 2018 or 2019 cancer program activity.  READ MORE .  PRODUCT SHOWCASE Help Doctors Without Borders Today Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more The CoC and the NAPBC need you! Become a member of the team that works with cancer programs and breast centers to ensure the provision of high-quality, patient-centered care to patients with cancer! If you are a practicing physician who recognizes the impact that CoC and NAPBC accreditation have on patient care, then you are encouraged to complete and submit an application to become a CoC and/or NAPBC surveyor. For additional information, refer to the CoC Surveyor Application or the NAPBC Surveyor Application. 2019 Quality and Safety Conference call for abstracts deadline ACS The American College of Surgeons has issued a call for abstracts to be presented at its 2019 Quality and Safety Conference, July 19-22, at the Washington Convention Center in Washington, D.C. The deadline for submitting abstracts is Feb. 1. Individuals at participating sites are encouraged to submit a 250-word abstract for poster and/or podium presentation. The abstract should relate to surgical quality improvement initiatives, including the development, implementation or validation of best practices. We are also interested in operational best practices relating to workflow around collecting data and reporting. Medical students and medical/surgical trainees are encouraged to submit research for the Best Trainee Abstract Competition. The primary author will be awarded a prize and invited to present at the conference. We encourage submissions from Cancer Programs, including the Commission on Cancer (CoC), National Accreditation Program for Breast Centers (NAPBC) and National Accreditation Program for Rectal Cancer (NAPRC). If you have an idea, start reaching out to your colleagues today. Get your team together and start planning your projects now. For more information or to submit an abstract, click here.     .  SPONSOR SPOTLIGHT     2019 surveys for National Accreditation for Program Breast Centers NAPBC Breast centers across the U.S. received notifications that preparations are underway for their centers will be surveyed in 2019. Their survey application records are open and ready to be filled with data through the NAPBC portal.  READ MORE  HEALTH CARE NEWS AND UPDATES Are the microbiome and cancer connected? $25 million project aims to find out Forbes The microbiome — the normal microbes we all have in our gut, is being increasingly linked to multiple aspects of health and disease. Now one of the world's biggest cancer charities, Cancer Research UK has dedicated up to $25 million to finding out if it is linked to development of colorectal cancer, the third most common cancer in the U.S.  READ MORE    SPONSORED CONTENT Promoted by InformedDNA Determining Breast Cancer Risk and Screening Methodologies Different Breast Cancer Genes Identify Different Risks, Not All Lead to Preventative Mastectomy Rebecca Sutphen, MD, FACMG, shares advice on when genetic counseling is beneficial for patients Genetics Services Programs from the nation’s largest, lab-independent, full-time staff of genetics experts in the U.S. A Guide to Achieving Measurable Results in Genetic Benefits Management   Is any part of our body cancer proof? ScienceNordic Cancer afflicts people in many parts of the body — including the breasts, lungs, colon, brain, bones and prostate. But what about other parts of the body that we don't hear about — like the heart or spleen? Are some organs more resistant to cancer than others? It may seem like it. You won't find heart, spleen or appendix cancers on the American National Cancer Institute's list of cancer types. This question demanded the expertise of researchers and professionals in the field.  READ MORE Psychosexual health and cancer International Federation of Gynecology and Obstetrics A study on psychosexual health in FIGO’s Updated Cancer Report 2018 shows how vital it is to treat every aspect of gynecologic cancer, not just the physical disease itself. A team led by the University of Cape Town examined data relating to sexual health after gynecologic cancers and treatment, and found that many women experience serious issues surrounding their sexual identity, sexual functioning and relationships.  READ MORE .  PRODUCT SHOWCASE Cancer Coding - Budget Preserving Processes Need to automate cancer coding at Budget Preserving costs? Let AI do the bulk coding and preserve valuable staff time for the most cryptic. HORIZON suite automates NAACR 2018 for 100% of your reportability assessments and 90%+ of your coding at better than manual accuracy, while undercutting manual costs. With ever-tightening budgets and workloads rising continuously and more data for analysis being demanded, www.hla-global.com is your best option for the future. Alisertib-based combo improves survival outcomes in ovarian, breast cancer CURE For some time now, paclitaxel has been considered standard of care in the treatment of patients with platinum-resistant ovarian cancer; however, recent research has shown the addition of the investigational drug alisertib to a paclitaxel regimen demonstrated promising activity in patients with recurrent ovarian cancer or advanced breast cancer. In the JAMA Oncology study, the researchers noted that alisertib has shown modest single-agent activity in patients with platinum-resistant ovarian and breast cancer, and is generally well tolerated.  READ MORE Can AI outperform doctors at detecting cervical cancer? Cancer Network A computer algorithm was able to accurately analyze digital images of cervical screenings and identify precancerous changes that required further medical follow-up, a new study showed. The new approach, called automated visual evaluation, has the potential to change point-of-care cervical screening.  READ MORE Why is uterine cancer on the rise? U.S. News & World Report It’s a headline no one wants to read, especially those of us in medicine: "More women in the United States are developing and dying from uterine cancer than they were 20 years ago, and African-American women are at an increased risk." But in late 2018, variations of this headline were splashed across the front pages of many medical and mainstream publications. Though uterine cancer is the most common cancer that can occur in a woman's reproductive organs, it isn't discussed as frequently as breast cancer or cervical cancer in women.  READ MORE Scientists discover new potential way to stop breast cancer spreading Forbes The chance of survival from breast cancer has dramatically increased in recent years, largely thanks to new treatments, but also due to better screening programs and awareness of the disease — leading to more women being diagnosed at an earlier stage. However, women who have tumors which have spread to other organs only have a five-year survival rate of 22 percent.  READ MORE Key advances in oncology, 2018 Cancer Network When considering the key advances in oncology this past year, the candidates are numerous. Oncology, by necessity, evolves at an ever more rapid pace. In 2018, the U.S. Food and Drug Administration approved a record 59 new drugs across all medical specialties; of these, 17 approvals were relevant to oncology/hematology specifically.  READ MORE  IMPORTANT DATES AND DEADLINES Date Event Location April 7-9, 2019 Cluster Programs Rosemont, IL   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063